K2 BioVentures

K2 BioVentures is a Houston-based venture studio and accelerator dedicated to advancing the next generation of cell and gene therapies. The company provides a comprehensive ecosystem that includes state-of-the-art laboratory space, process development, and manufacturing services through its K2 Bio arm. By partnering with academic institutions and early-stage biotechs, K2 BioVentures aims to de-risk drug development and streamline the path from discovery to clinical application. Their model integrates investment capital with operational expertise to foster innovation in the life sciences sector, specifically within the Texas Medical Center ecosystem. The firm focuses on identifying high-potential therapeutic candidates and providing the necessary infrastructure to move them through the pre-clinical phase. This integrated approach allows for rapid scaling and optimization of complex modalities like CAR-T and NK cell therapies.